News

The new data shows that mice on a high-fat diet treated with one of Sirtris’s new chemical entities (NCEs) remained lean while consuming the same number of calories

In Australia, Revlimid (lenalidomide) has received marketing authorization approval from the Australian Therapeutic Goods Administration (TGA) for use in combination with dexamethasone as a treatment for patients with

The suit was filed in the US District Court in Newark, New Jersey. The suit claims the companies have known since 2006 that the combination of drugs was

The Data Safety Monitoring Board (DSMB) has conducted a safety analysis of defibrotide as part of the interim analysis and concluded that there are no safety concerns at

Pending the SFDA’s review of conformity to product standard documents and labeling to applicable regulations, the application will progress to the concluding administrative approval. The Aware HIV-1/2 OMT

Under the terms of the agreement, Quantum Genomics (QGC) retains the right to acquire the intellectual property generated by Inserm and to exploit associated know-how. QGC will fund

The company has asked the FDA for permission to initiate a clinical trial of the Zenith Branch Endovascular Graft-Iliac Bifurcation with the H&L-B One Shot Introduction System at

In addition, Orexigen has granted the underwriters a 30-day option to purchase an additional 1.05 million shares to cover overallotments, if any. Merrill Lynch & Co. acted as

The new products, the Trinity Biotech EU Lyme IgG + VlsE EIA and the EU Lyme IgM EIA are designed for use as screening assays in clinical laboratories.